- Home
- IVR vs HUMA Comparison
IVR vs HUMA Comparison
Compare IVR & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVR
- HUMA
- Stock Information
- Founded
- IVR 2008
- HUMA 2004
- Country
- IVR United States
- HUMA United States
- Employees
- IVR N/A
- HUMA N/A
- Industry
- IVR Real Estate Investment Trusts
- HUMA Biotechnology: Pharmaceutical Preparations
- Sector
- IVR Real Estate
- HUMA Health Care
- Exchange
- IVR Nasdaq
- HUMA Nasdaq
- Market Cap
- IVR 515.0M
- HUMA 577.7M
- IPO Year
- IVR 2009
- HUMA N/A
- Fundamental
- Price
- IVR $8.38
- HUMA $4.64
- Analyst Decision
- IVR Buy
- HUMA Strong Buy
- Analyst Count
- IVR 2
- HUMA 7
- Target Price
- IVR N/A
- HUMA $13.14
- AVG Volume (30 Days)
- IVR 1.3M
- HUMA 6.3M
- Earning Date
- IVR 11-05-2024
- HUMA 11-08-2024
- Dividend Yield
- IVR 19.12%
- HUMA N/A
- EPS Growth
- IVR N/A
- HUMA N/A
- EPS
- IVR 1.23
- HUMA N/A
- Revenue
- IVR $102,893,000.00
- HUMA N/A
- Revenue This Year
- IVR N/A
- HUMA N/A
- Revenue Next Year
- IVR $6.62
- HUMA $6,438.24
- P/E Ratio
- IVR $6.81
- HUMA N/A
- Revenue Growth
- IVR 654.96
- HUMA N/A
- 52 Week Low
- IVR $7.60
- HUMA $2.48
- 52 Week High
- IVR $9.97
- HUMA $9.97
- Technical
- Relative Strength Index (RSI)
- IVR 49.61
- HUMA 53.53
- Support Level
- IVR $8.17
- HUMA $3.37
- Resistance Level
- IVR $8.65
- HUMA $4.42
- Average True Range (ATR)
- IVR 0.18
- HUMA 0.50
- MACD
- IVR -0.01
- HUMA 0.01
- Stochastic Oscillator
- IVR 48.19
- HUMA 37.35
About IVR INVESCO MORTGAGE CAPITAL INC
Invesco Mortgage Capital Inc is a REIT that invests, finances, and manages residential and commercial mortgage-backed securities and mortgage loans. The company's portfolio consists of residential mortgage-backed securities (RMBS) that are guaranteed by a U.S. government agency such as the Government National Mortgage Association, or a federally chartered corporation such as the Federal National Mortgage Association or the Federal Home Loan Mortgage Corporation; Commercial mortgage-backed securities (CMBS) that are not guaranteed by a U.S. government agency or a federally chartered corporation; RMBS that are not guaranteed by a U.S. government agency or a federally chartered corporation; and other real estate-related financing arrangements.
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions.